192. Cockayne syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 5 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 49
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Prodarsan
DNage B.V.
2010 Phase 1/Phase 2 NCT01142154 United States
Quercetin
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China
Sirolimus
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vehicle
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vitamin C
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China
DNage B.V.
2010 Phase 1/Phase 2 NCT01142154 United States
Quercetin
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China
Sirolimus
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vehicle
Premier Specialists, Australia
2016 Phase 2 NCT03016715 Australia
Stanford University
2016 Phase 2 NCT02960997 United States
Vitamin C
The First Medical Center of PLA General Hospital
2019 Phase 0 ChiCTR1900026719 China